Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Multiple Myeloma × carfilzomib × Clear all

Status

Completed 54 Active not recruiting 36 Recruiting 22 Terminated 20 Unknown 7 Withdrawn 6 Not yet recruiting 6 No longer available 1 Enrolling by invitation 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

talquetamab 1 pomalidomide 1 daratumumab 1 carfilzomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01410500 2017-05-02

Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease

Amgen

Approved for marketing

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡